Abstract:Background: As a highly aggressive cancer, hepatocellular carcinoma (HCC) is often found at an advanced stage and has a poor prognosis. Therefore, in addition to the surgical treatment of HCC, the drug therapy for HCC is still under continuous exploration. The primary apolipoprotein of high-density lipoproteins (HDLs) is apolipoprotein A-I binding protein (AIBP), which has a significant impact on cholesterol metabolism, angiogenesis, and a wide range of inflammatory disorders, including cancer. The AIBP function in HCC is, however, yet unknown. This study aims to reveal the underlying mechanisms of AIBP influencing HCC proliferation and migration through mitogen-activated protein kinase (MAPK) pathways. Methods: AIBP expression and its clinical prognostic association were investigated using The Cancer Genome Atlas (TCGA) data. The AIBP expression was studied in human HCC tissues using immunohistochemistry (IHC) and western blotting. Colony formation assays (CFAs) and cell counting kit-8 (CCK-8) were used to determine in vitro cell proliferation. Cell migration and invasion were evaluated using wound-healing and transwell assays. A xenograft tumor model was employed to investigate HCC cell proliferation in nude mice. Results: Tissues from HCC patients had much increased AIBP expression compared to nearby normal tissues. The prognosis for patients was bleak when AIBP expression was high. When AIBP was overexpressed in SMMC-7721 cells, the cells may become more proliferative, migrative, and invasive. In contrast, the HCC-LM3 cells' ability to proliferate, migrate, and invade was drastically decreased once AIBP was knocked down in vitro. Furthermore, in vivo research showed that AIBP overexpression may enhance cell proliferation in HCC. Finally, we discovered that AIBP could control the MAPK signaling pathway-involved genes expression, including P-MEK, MEK, c-Myc, P-ERK1/2, and ERK1/2, and that GDC-0994, a specific ERK1/2 inhibitor, could suppress the AIBP overexpression induced cell migration and proliferation abilities. Conclusions: These findings demonstrated that the ERK/MAPK signaling pathway might be stimulated by AIBP in HCC tissues, leading to increased cell invasion, migration, and proliferation. It was hypothesized that AIBP might act as a useful prognostic and diagnostic marker for HCC.

Stress Hormone Epinephrine Promoting the Growth of Human Hepatocellular Carcinoma Cells Via Β2-Ar-mediated Activation of ERK1/2

The mitogenic effectors of isoproterenol in human hepatocellular carcinoma cells.

Epidermal Growth Factor Induces Proliferation of Human Hepatoma HepG2 Cells and Its Mechanism of Action

Chrysanthemum Indicum Linné Extracts Attenuate the Mitogenic Effect of Epinephrine on Human HCC Cells

Human growth hormone and human prolactin function as autocrine/paracrine promoters of progression of hepatocellular carcinoma.

Stress-induced epinephrine promotes hepatocellular carcinoma progression via the USP10-PLAGL2 signaling loop

Stimulation of the Mitogen-activated Protein Kinase Cascade and Tyrosine Phosphorylation of the Epidermal Growth Factor Receptor by Hepatopoietin*

Gastrin-releasing Peptide Promotes the Growth of HepG2 Cells Via EGFR-independent ERK1/2 Activation.

Enoyl-coenzyme A Hydratase, Short Chain 1 Involved in Promoting the Proliferation of Hepatocellular Carcinoma HepG2 Cells

PGE2 Synthesis and Signaling in Malignant Transformation and Progression of Human Hepatocellular Carcinoma.

Effects of PI3K and P42/p44 MAPK on Overexpression of Vascular Endothelial Growth Factor in Hepatocellular Carcinoma.

Inhibition of ERK1/2 Signaling Impairs the Promoting Effects of TGF-β1 on Hepatocellular Carcinoma Cell Invasion and Epithelial-Mesenchymal Transition.

Erianin suppresses hepatocellular carcinoma cells through down-regulation of PI3K/AKT, p38 and ERK MAPK signaling pathways.

The role of EGF-EGFR signalling pathway in hepatocellular carcinoma inflammatory microenvironment.

Epidermal growth factor promotes the invasion of human cholangiocarcinoma cells by activating nuclear factor kappa B

Β2-Adrenergic Receptor Activation Promotes the Proliferation of A549 Lung Cancer Cells Via the ERK1/2/CREB Pathway.

Epirubicin Enhances the Anti-Cancer Effects of Radioactive 125I Seeds in Hepatocellular Carcinoma via Downregulation of the JAK/STAT1 Pathway

Human leptin protein activates the growth of HepG2 cells by inhibiting PERK‑mediated ER stress and apoptosis.

AIBP promotes cell proliferation and migration through the ERK1/2-MAPK signaling pathway in hepatocellular carcinoma

Increased Expression of EphA2 and E-N Cadherin Switch in Primary Hepatocellular Carcinoma.

Angiotensin II Enhances Proliferation and Inflammation through AT1/PKC/NF-κB Signaling Pathway in Hepatocellular Carcinoma Cells